ST Pharm has struck a $56 million deal with an undisclosed U.S.-based biotech to produce active pharmaceutical ingredients (APIs) for a new oligonucleotide treatment. The Korean CDMO revealed the contract Friday in a regulatory filing.
ST Pharm inks $56M deal to produce API for a US biotech
Latest from Blog
A nutritionist’s 12 kitchen staples for quick, nutrient-dense meals
Rob Hobson, a nutritionist, shared 12 convenient foods that provide a big dose of nutrition per bite. Post Views: 1
Antioxidant Rich Fruit Oils Market Forecast Points Higher Toward 2035 Driven by Clean Beauty and Functional Nutrition Demand
World Antioxidant Rich Fruit Oils Market analysis 2026-2035: CAGR forecast, key drivers, restraints, end-use sectors, and regional outlook. Post Views: 1
Letter: It’s time to celebrate beef, a powerhouse of nutrition
As a cow-calf producer near Rugby, I’m grateful to ranch alongside my family and be part of an industry that feeds people, fuels our economy and sustains our land. Post Views: 1
The simple nutrition mistake many men make—once I realized it, my energy changed all day
Like many people, I focused more on convenience in the morning than on nutrition. Post Views: 1
The surprisingly strong case for feeling great about your coffee habit
Your morning coffee is one of modern life’s underrated miracles. Post Views: 1